Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Q4FY21 Result Update - Hindustan Unilever - ICICI Direct

Posted On: 2021-05-02 02:42:06 (Time Zone: UTC)


HUL posted strong set of results with 34.6% revenue growth led by 16% volume growth. Though the growth was aided by the low base quarter & consolidation of foods business, discretionary categories also saw a sharp recovery in Q4FY21. Home care and beauty & personal care (BPC) segments witnessed growth of 14.6% & 19.7%, respectively. Detergent category, which was adversely impacted in 9MFY21 saw strong recovery in Q4 due to increase in out of home activity. The growth in BPC category was also driven by volume as well as calibrated price hikes in the soaps category. Foods business grew 96% due to consolidation of nutrition business but on a like-to-like basis, the segment growth was 36%. Gross margins contracted 117 bps mainly on account of a sharp increase in palm oil, tea & crude based raw material prices. However, the company was able to pass on the increase in raw material cost partially in the last six months. Marketing spends & other overhead spends were down 127 bps & 172 bps, respectively. This helped the company grow its operating profit by 43.2% to Rs. 2957 crore. Operating margins improved 146 bps to 24.4%. Led by strong operating profit growth, PAT witnessed growth of 41.1% to Rs. 2143 crore. The company declared a final dividend of Rs. 17/share.

Valuation & Outlook

Given strong growth in nutrition business, judicious price hikes and continued strong growth in hygiene & foods business, we estimate 11.8% revenue growth in FY21-23E. We believe synergetic benefits of acquired nutrition brands would reflect in margin expansion, going forward, and expect earnings CAGR of 15.3% in FY21-23E. We change our rating from HOLD to BUY with a revised TP of Rs. 2715/share (earlier Rs. 2600).

For details, click on the link below: https://www.icicidirect.com/mailimages/IDirect_HUL_Q4FY21.pdf

Shares of HINDUSTAN UNILEVER LTD. was last trading in BSE at Rs.2353.85 as compared to the previous close of Rs. 2409.05. The total number of shares traded during the day was 178827 in over 16485 trades.

The stock hit an intraday high of Rs. 2444.45 and intraday low of 2331. The net turnover during the day was Rs. 422662868.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

Maintain BUY on CreditAccess Grameen - Accelerated write-offs dents earnings - HDFC Securities

Sundram Fasteners Q4 Results Review - HDFC Securities

SRF - Specialty Chemicals continues to shine! - HDFC Securities

Realtors welcome RBI latest stance, expect relief initiatives in next announcement

CreditAccess Grameen - Q4FY21 Result Update - ICICI Securities

JM Financial - Exits FY21 with well contained stress pool; sequential AUM uptick encouraging - ICICI Securities

Hero MotoCorp - Margins remain resilient - ICICI Securities

CEAT - Margin pressures likely to intensify - ICICI Securities

SRF Limited - FY22E growth capped on higher plants utilisation - ICICI Securities

I-direct Instinct - Automotive Axles - ICICI Direct

Quant Pick - Axis Bank - ICICI Direct

Gladiator Stocks - Caplin Point Laboratories - ICICI Direct

Q4FY21 Result Update - Coforge Ltd - ICICI Direct

Tata Consumer Products - Q4FY21 First Cut - ICICI Direct

Coforge Ltd - Q4FY21 Result Update - YES Securities

CreditAccess Grameen - Q4FY21 Result Update - YES Securities

Blue Star - Q4 FY21 first cut - Inline performance - YES Securities

Tata Consumer - 4QFY21 results first cut - YES Securities

Tata Consumer 4QFY21 results first cut - YES Securities

Maintain BUY on CDSL - Strong growth momentum - HDFC Securities

Maintain ADD on L&T Infotech - Steady progression - HDFC Securities

Blue Dart Express - Q4FY21 - The bulge continues - ICICI Securities

Tata Steel - FY22E Net Debt/EBITDA at <1x - ICICI Securities

Larsen & Toubro Infotech - Consistency continues! - ICICI Securities

CEAT - Decent quarter; new capex likely to curtail FCF - ICICI Securities

Q4FY21 Result Update - Alembic Pharma - ICICI Direct

Gladiator Stocks - Cadila Healthcare - ICICI Direct

Q4FY21 Result Update - Larsen & Toubro Infotech - ICICI Direct

RBI Action Update - May 2021 - ICICI Direct

Quant Pick - Aurobindo Pharma - ICICI Direct

Q4FY21 Result Update - Greaves Cotton - ICICI Direct

Adani Total Gas Ltd - Q4FY21 Result Update - YES Securities

L&T Infotech - Q4FY21 Result Update - YES Securities

Bluedart Express - Q4 FY21 first cut - Miss on topline; Profitability improves - YES Securities

Views on the announcement by RBI Governor - Ms. Bekxy Kuriakose, Head - Fixed Income, Principal Asset Management

Views from experts on RBI announcement - May 5, 2021

Maintain REDUCE on RBL Bank - Elevated retail slippages continue - HDFC Securities

Resolution 2.0 measure by RBI to provide relief to real estate linked SME stakeholders

Godrej Properties - Robust quarter; positives fairly priced in - HDFC Securities

RBI Relief 2.0 - May 2021 - Acuité Ratings & Research

MDF Industry - Countervailing duty on MDF recommended; imports may get hit structurally - ICICI Securities

Home First Finance Company - Core earnings steady; profitability buoyed by securitisation income - ICICI Securities

RBL Bank - Modest return profile in the interim; transitioning underway - ICICI Securities

Alembic Pharmaceuticals - US continues to be under pressure - ICICI Securities

Q4FY21 Result Update - SBI Life Insurance - ICICI Direct

Q1CY21 Result Update - Varun Beverages - ICICI Direct

RBL Bank: Views from leading research houses on Q4FY21 results

Q4FY21 Result Update - Supreme Industries - ICICI Direct

Q4FY21 Result Update - Tata Chemicals - ICICI Direct

Larsen & Toubro Infotech - Q4FY21 First Cut - ICICI Direct


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020